The company has introduced an innovative Dual Release Proton Pump Inhibitor (PPI) tablet, a next-generation therapy for patients suffering from moderate to severe or treatment resistant gastroesophageal reflux disease
Dr Agarwals Health Care has reported total income of Rs. 506.62 crore during the period ended September 30, 2025
Dabur India has reported total income of Rs. 3,331.45 crore during the period ended September 30, 2025
Dr Agarwals Eye Hospital has reported total income of Rs. 118.40 crore during the period ended September 30, 2025
The upcoming state-of-the art 400+ bed facility is set to come up at an approximate cost of Rs 500 crore
Tatva Chintan Pharma Chem has reported total income of Rs. 124.52 crore during the period ended September 30, 2025
Indraprastha Medical Corporation has reported total income of Rs. 388.40 crore during the period ended September 30, 2025
Medplus Health Services has reported total income of Rs. 1,696.79 crore during the period ended September 30, 2025
Performance driven by growth portfolio momentum, pipeline advancements, and strategic business development
Subscribe To Our Newsletter & Stay Updated
